Nxtech Inc.
Patchogue, NY
- UEI
- XLK6RTZF2MG4
- CAGE
- 89PH8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 198 E Lakewood St, Patchogue, NY 11772, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Boostprime, a novel digital therapeutic for craving mitigation in OUD | National Institute on Drug Abuse (NIH) | $3,669,336 | |
| Innovation corps supporting boostone sbir | National Institute on Drug Abuse (NIH) | $846,944 |
Quick answers
Is Nxtech Inc. registered in SAM.gov?
Yes. Nxtech Inc.'s SAM.gov registration is active through May 16, 2027.
What is Nxtech Inc.'s most recent federal award?
Nxtech Inc.'s most recent federal grant award is Boostprime, a novel digital therapeutic for craving mitigation in OUD (R44DA058531), from National Institute on Drug Abuse (NIH), on April 15, 2023.
On GovTribe
See Nxtech Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors